Patents by Inventor GIACOMO SALVADORE

GIACOMO SALVADORE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods For The Treatment Of Depression
    Publication number: 20230089113
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Application
    Filed: April 22, 2022
    Publication date: March 23, 2023
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Maria Canuso, Margaret Fedgchin, Frank Wiegand, Giacomo Salvadore
  • Methods For The Treatment Of Depression
    Publication number: 20200246279
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Application
    Filed: December 26, 2019
    Publication date: August 6, 2020
    Inventors: Lodewijk Ivo Caers, Giacomo Salvadore, Jaskaran Singh
  • VAL66MET (SNP rs6265) GENOTYPE SPECIFIC DOSING REGIMENS AND METHODS FOR THE TREATMENT OF DEPRESSION
    Publication number: 20160074340
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations) comprising genotyping a patient to determine their Val66Met rs6265 polymorphism in BDNF and administering a ketamine, preferably esketamine, preferably intranasal esketamine, according to a dosing regimen matched to the patient's genotype.
    Type: Application
    Filed: September 14, 2015
    Publication date: March 17, 2016
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: LODEWIJK IVO CAERS, GIACOMO SALVADORE, JASKARAN SINGH